|
|
Article: Geron receives favorable ruling in nuclear transfer patent interference matter.
- Article from:
- Medical Devices & Surgical Technology Week
- Article date:
- February 15, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 FEB 15 - (NewsRx.com & NewsRx.net) -- Geron Corp. (GERN) announced that the board of Patent Appeals and Interferences of the U.S. Patent and Trademark Office has issued a decision on motions filed in the patent interference proceeding between Geron and Infigen, Inc., of DeForest, Wisconsin.
The decision upholds the patentability of all of Geron's claims and finds all of the Infigen claims to be unpatentable.
The interference is between a patent application licensed to Geron from the Roslin Institute and an Infigen patent application. Both applications claim patent rights to animal cloning technology. The board's decision:
1) confirms that ...